| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRVL | Common Stock | Options Exercise | $0 | +2,187 | +2.7% | $0.000000 | 84,118 | 15 Apr 2025 | By Trust | F1 |
| transaction | MRVL | Common Stock | Tax liability | $57,852 | -1,085 | -1.3% | $53.32 | 83,033 | 15 Apr 2025 | By Trust | F1, F2 |
| transaction | MRVL | Common Stock | Options Exercise | $0 | +1,367 | +1.6% | $0.000000 | 84,400 | 15 Apr 2025 | By Trust | F1 |
| transaction | MRVL | Common Stock | Tax liability | $36,151 | -678 | -0.8% | $53.32 | 83,722 | 15 Apr 2025 | By Trust | F1, F2 |
| transaction | MRVL | Common Stock | Options Exercise | $0 | +4,497 | +5.4% | $0.000000 | 88,219 | 15 Apr 2025 | By Trust | F1 |
| transaction | MRVL | Common Stock | Tax liability | $118,904 | -2,230 | -2.5% | $53.32 | 85,989 | 15 Apr 2025 | By Trust | F1, F2 |
| transaction | MRVL | Common Stock | Options Exercise | $0 | +2,788 | +3.2% | $0.000000 | 88,777 | 15 Apr 2025 | By Trust | F1 |
| transaction | MRVL | Common Stock | Tax liability | $73,742 | -1,383 | -1.6% | $53.32 | 87,394 | 15 Apr 2025 | By Trust | F1, F2 |
| transaction | MRVL | Common Stock | Options Exercise | $0 | +33,066 | +38% | $0.000000 | 120,460 | 15 Apr 2025 | By Trust | F1 |
| transaction | MRVL | Common Stock | Tax liability | $874,181 | -16,395 | -14% | $53.32 | 104,065 | 15 Apr 2025 | By Trust | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -2,187 | -100% | $0.000000 | 0 | 15 Apr 2025 | Common Stock | 2,187 | Direct | F3, F4 | |
| transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -1,367 | -100% | $0.000000 | 0 | 15 Apr 2025 | Common Stock | 1,367 | Direct | F3, F4 | |
| transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -4,497 | -20% | $0.000000 | 17,989 | 15 Apr 2025 | Common Stock | 4,497 | Direct | F3, F5 | |
| transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -2,788 | -11% | $0.000000 | 22,300 | 15 Apr 2025 | Common Stock | 2,788 | Direct | F3, F6 | |
| transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -33,066 | -100% | $0.000000 | 0 | 15 Apr 2025 | Common Stock | 33,066 | Direct | F3, F7 | |
| transaction | MRVL | Restricted Stock Units | Award | $0 | +48,923 | $0.000000 | 48,923 | 15 Apr 2025 | Common Stock | 48,923 | Direct | F3, F8 |
| Id | Content |
|---|---|
| F1 | Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust. |
| F2 | Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). |
| F3 | Each RSU represents a contingent right to receive one Marvell common share upon vesting. |
| F4 | This grant fully vested on 04/15/2025. |
| F5 | The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026 and 04/15/2026. |
| F6 | The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. |
| F7 | The grant is fully vested. Reflects the number of shares earned in respect of performance based restricted stock units granted on 04/15/2022. The achievement levels of the relative TSR performance metrics applicable to the award and the number of shares earned based on such results that were certified on 04/15/2025. |
| F8 | The RSUs will vest in equal quarterly installments over three years, and were granted as part of the annual grant process. |